Biocompatibility and paclitaxel/cisplatin dual-loading of nanotubes prepared from poly(ethylene glycol)-polylactide-poly(ethylene glycol) triblock copolymers for combination cancer therapy.

Saudi Pharm J · 2019 · PMC6978636 · PMID 31997910

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

extremely significantno p-value reported

Values of p > 0.05 were considered not significant, p < 0.05 statistically significant, p < 0.01 very significant, and p < 0.001 extremely significant. 3.

also in 7,787 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.